No need to get aggressive, wouldnt end well.
I get the difference, I believe there would be a report provoded at the conclusion of trials. Im not from industry, I dont know terminology etc, but it makes sense.
Up for debate imo is what would such a report contain, do developers always release it to market, is there any reason why it wouldn't have been received in this instance
Not trying to twist facts, but you were clearly of the opinion in Feb that they had received it. I thought that view waa logical, they said or inferred they would right?
i think its material in the scheme of things.
So not looking to offend, just clarify. Whats your view on it now?
Ill come back on the other point if you like, not sure you explicitly said you did. But I suspect there was inference and some fairly explicit opinions around what BP do or do not do.
As I said in one of my original posta I see these things as a matter of logical deduction based on available information. Doesnt mean we get a definitive answer, and we have to wade through some unintended and otherwise misdirection, but hey, looks like we have time on our side.
So definitely value what you have to say, even if I disagree. Thanks for the feedback on post too, written between wedding and reception.... couldve developed it more, but clearly hit my word limit based on feedback
- Forums
- ASX - By Stock
- BIT
- $30 Billion Deal
$30 Billion Deal, page-4647
-
-
- There are more pages in this discussion • 433 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIT (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.5¢ |
Change
0.002(6.06%) |
Mkt cap ! $31.57M |
Open | High | Low | Value | Volume |
3.3¢ | 3.5¢ | 3.3¢ | $19.27K | 566.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 299989 | 3.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.5¢ | 371664 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 299989 | 0.034 |
3 | 240016 | 0.033 |
2 | 242406 | 0.032 |
6 | 600480 | 0.031 |
9 | 670666 | 0.030 |
Price($) | Vol. | No. |
---|---|---|
0.035 | 371664 | 3 |
0.036 | 65500 | 1 |
0.037 | 767816 | 3 |
0.039 | 430546 | 2 |
0.040 | 113240 | 2 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
BIT (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online